Rechallenge with anti-EGFR-based therapy in metastatic colorectal cancer: Impact of intervening time interval and prior anti-EGFR response.

被引：0
|
作者：
Liu, Xiaochun
George, Goldy C.
Tsimberidou, Apostolia Maria
Naing, Aung
Wheler, Jennifer J.
Kopetz, Scott
Fu, Siqing
Piha-Paul, Sarina Anne
Eng, Cathy
Falchook, Gerald Steven
Janku, Filip
Garrett, Chris R.
Karp, Daniel D.
Kurzrock, Razelle
Zinner, Ralph
Raghav, Kanwal Pratap Singh
Subbiah, Vivek
Meric-Bernstam, Funda
Hong, David S.
Overman, Michael J.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Program 1, Houston, TX 77030 USA
[4] Univ Calif San Diego, La Jolla, CA 92093 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.3607
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3607
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
    Liu, X.
    George, G. C.
    Tsimberidou, A. M.
    Naing, A.
    Wheler, J. J.
    Kopetz, S.
    Fu, S.
    Piha-Paul, S. A.
    Eng, C.
    Falchook, G. S.
    Janku, F.
    Garrett, C.
    Karp, D.
    Kurzrock, R.
    Zinner, R.
    Raghav, K.
    Subbiah, V.
    Hess, K.
    Meric-Bernstam, F.
    Hong, D. S.
    Overman, M. J.
    BMC CANCER, 2015, 15
  • [2] Retreatment with anti-EGFR based therapies in metastatic colorectal cancer: impact of intervening time interval and prior anti-EGFR response
    X. Liu
    G. C. George
    A. M. Tsimberidou
    A. Naing
    J. J. Wheler
    S. Kopetz
    S. Fu
    S. A. Piha-Paul
    C. Eng
    G. S. Falchook
    F. Janku
    C. Garrett
    D. Karp
    R. Kurzrock
    R. Zinner
    K. Raghav
    V. Subbiah
    K. Hess
    F. Meric-Bernstam
    D. S. Hong
    M. J. Overman
    BMC Cancer, 15
  • [3] Biomarker-Guided Anti-Egfr Rechallenge Therapy in Metastatic Colorectal Cancer
    Ciardiello, Davide
    Martini, Giulia
    Famiglietti, Vincenzo
    Napolitano, Stefania
    De Falco, Vincenzo
    Troiani, Teresa
    Latiano, Tiziana Pia
    Ros, Javier
    Elez Fernandez, Elena
    Vitiello, Pietro Paolo
    Maiello, Evaristo
    Ciardiello, Fortunato
    Martinelli, Erika
    CANCERS, 2021, 13 (08)
  • [4] Liquid biopsy driven anti-EGFR rechallenge in metastatic colorectal cancer
    Puzzoni, M.
    Giampieri, R.
    Mariani, S.
    Ziranu, P.
    Pusceddu, V.
    Donisi, C.
    Persano, M.
    Pinna, G.
    Cimbro, E.
    Parrino, A.
    Pretta, A.
    Lai, E.
    Liscia, N.
    Lupi, A.
    Giglio, E.
    Palomba, G.
    Casula, M.
    Pisano, M.
    Palmieri, G.
    Scartozzi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S543 - S544
  • [5] ANTI-EGFR ANTIBODY RECHALLENGE IN CHEMOREFRACTORY PATIENTS WITH METASTATIC COLORECTAL CANCER
    Kajitani, Tatsuhiro
    Makiyama, Akitaka
    Arita, Shuji
    Kumagai, Hozumi
    Oda, Hisanobu
    Shirakawa, Tsuyoshi
    Esaki, Taito
    ANNALS OF ONCOLOGY, 2014, 25
  • [6] Rechallenge with anti-EGFR therapy to extend the continuum of care in patients with metastatic colorectal cancer
    Cremolini, Chiara
    Montagut, Clara
    Ronga, Philippe
    Venturini, Filippo
    Yamaguchi, Kensei
    Stintzing, Sebastian
    Sobrero, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 12
  • [7] MicroRNAs and response to anti-EGFR therapy in metastatic colorectal cancer.
    Blanco-Calvo, Moises
    Haz-Conde, Mar
    Rodriguez-Rigueiro, Teresa
    Figueroa, Angelica
    Reboredo, Margarita
    Medina Villaamil, Vanessa
    Lorenzo-Patino, Maria J.
    Arnal, Francisco
    Anton-Aparicio, Luis
    Alonso-Jaudenes Curbera, Guillermo
    Valladares-Ayerbes, Manuel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Rechallenge with anti-EGFR antibodies in metastatic colorectal cancer: A single center analysis
    Duarte Mendes, A.
    Vicente, R.
    Caleca, T.
    Silva, M.
    ANNALS OF ONCOLOGY, 2023, 34 : S149 - S149
  • [9] Does bevacizumab impact anti-EGFR therapy efficacy in metastatic colorectal cancer?
    Derangere, Valentin
    Fumet, Jean David
    Boidot, Romain
    Bengrine, Leila
    Limagne, Emeric
    Chevriaux, Angelique
    Vincent, Julie
    Ladoire, Sylvain
    Apetoh, Lionel
    Rebe, Cedric
    Ghiringhelli, Francois
    ONCOTARGET, 2016, 7 (08) : 9310 - 9322
  • [10] Anti-EGFR Therapy to Treat Metastatic Colorectal Cancer: Not for All
    Martins, Marta
    Mansinho, Andre
    Cruz-Duarte, Raquel
    Martins, Soraia Lobo
    Costa, Luis
    TARGETED THERAPY OF COLORECTAL CANCER SUBTYPES, 2018, 1110 : 113 - 131
12345